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Abstract
Background: Using human brain microvascular endothelial cells (HBMECs) as an in vitro model for how African
trypanosomes cross the human blood-brain barrier (BBB) we recently reported that the parasites cross the BBB by
generating calcium activation signals in HBMECs through the activity of parasite cysteine proteases, particularly cathepsin L
(brucipain). In the current study, we examined the possible role of a class of protease stimulated HBMEC G protein coupled
receptors (GPCRs) known as protease activated receptors (PARs) that might be implicated in calcium signaling by African
trypanosomes.
Methodology/Principal Findings: Using RNA interference (RNAi) we found that in vitro PAR-2 gene (F2RL1) expression in
HBMEC monolayers could be reduced by over 95%. We also found that the ability of Trypanosoma brucei rhodesiense to
cross F2RL1-silenced HBMEC monolayers was reduced (39%–49%) and that HBMECs silenced for F2RL1 maintained control
levels of barrier function in the presence of the parasite. Consistent with the role of PAR-2, we found that HBMEC barrier
function was also maintained after blockade of Gaq with Pasteurella multocida toxin (PMT). PAR-2 signaling has been shown
in other systems to have neuroinflammatory and neuroprotective roles and our data implicate a role for proteases (i.e.
brucipain) and PAR-2 in African trypanosome/HBMEC interactions. Using gene-profiling methods to interrogate candidate
HBMEC pathways specifically triggered by brucipain, several pathways that potentially link some pathophysiologic
processes associated with CNS HAT were identified.
Conclusions/Significance: Together, the data support a role, in part, for GPCRs as molecular targets for parasite proteases
that lead to the activation of Gaq-mediated calcium signaling. The consequence of these events is predicted to be increased
permeability of the BBB to parasite transmigration and the initiation of neuroinflammation, events precursory to CNS
disease.
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Introduction
Human African trypanosomiasis (HAT), commonly called
sleeping sickness, is a vector-borne disease for which death is
inevitable if the patient is untreated [1,2,3]. HAT is caused by two
subspecies of African trypanosomes, Trypanosoma brucei rhodesiense
and T. b. gambiense causing East African and West African sleeping
sickness, respectively. In classical late stage HAT (stage 2), the
parasites invade the central nervous system (CNS) and the infected
individuals suffer from progressive neurologic deterioration with
concomitant psychiatric disorders, sleep disturbances, stupor, and
coma. The role of the parasites in the pathogenesis of CNS lesions
is not completely understood [4].
Usinganinvitromodeloftheblood-brainbarrier(BBB)consistingof
human brain microvascular endothelial cells (HBMEC), we showed
that human infective T. b. rhodesiense have a high potential for
transendothelial migration, while animal infective T. b. brucei cross
inefficiently [5]. We initially proposed that African trypanosome
www.plosntds.org 1 July 2009 | Volume 3 | Issue 7 | e479associated protease(s) could mediate the process of parasite traversal
across the BBB [6]. In vitro studies utilizing both cysteine protease
inhibitors and RNA interference (RNAi) have identified a key role for
the T. brucei Clan CA (papain) family of cysteine proteases in the
lifecycle of T. b. brucei [7,8]. The T. brucei genome encodes two distinct
Clan CA cysteine proteases. Brucipain (aka trypanopain-Tb,r h o d e -
sain) is a cathepsin L-like protease responsible for the bulk of protease
activity in the organism[7]. T. brucei cathepsin B (TbCatB) has activity
that is upregulated in the bloodstream form (BSF) of the parasites [7].
Remarkably, it was found that the ability of the parasites to cross
HBMECs through the generation of PLC/PKC mediated Ca
2+
activation signals correlated with levels of brucipain activity [9,10].
RNAi studies investigating the roles played by TbCatB and brucipain
inthepathogenesisofT.b.bruceiinvivoalsosuggestedbrucipainpossibly
facilitates parasite entry into the CNS [11].
Cysteine proteases can activate a class of G protein coupled
receptors (GPCR) known as protease activated receptors (PARs).
In neutrophils and oral epithelial cells PAR activation by
gingipain, a cysteine protease of Porphyromonas gingivalis, leads to
calcium signaling and IL-6 production [12,13,14]. HBMEC
express all 4 protease activated receptors (PARs), and activation
of PAR-1 and PAR-2 has been shown to trigger calcium mediated
BMEC transmembrane signaling [15]. Since we observed
activating signals (increases in [Ca
2+]i and phospholipase C
activation) during the interaction of African trypanosomes with
HBMECs [5,9,10], we hypothesized that the activation of PARs
by the parasite could also play a role in increasing HBMEC
permeability, enabling subsequent crossing [4]. We now show that
African trypanosome traversal across the human BBB requires, at
least in part, the participation of a PAR-2-mediated calcium
signaling pathway(s).
Materials and Methods
Chemicals
N-methyl-Pip-F-homoF-vinyl sulfonyl phenyl (K11777) [16,17],
an irreversible inhibitor of Trypanosoma cruzi Clan A cysteine
protease cruzipain [17] was a gift from Dr. James McKerrow
(University of California at San Francisco).
Purification of recombinant Pasteurella multocida toxin
Recombinant Pasteurella multocida toxin (PMT) was cloned,
expressed, purified, quantified, and tested for biological activity
as previously described [18]. The toxin samples were stored at
280uC until use.
HBMEC and trypanosomes
Primary HBMECs (# passage 13) were maintained as
previously described [5,9,15]. The bloodstream form (BSF) T. b.
rhodesiense used was originally obtained from the CSF from a
Kenyan patient with sleeping sickness [5,9,10]. This parasite was
formerly classified as T. b. gambiense IL1852, but has been
reclassified as T. b. rhodesiense IL1852 based on the presence of
the SRA gene [10]. The bloodstream form (BSF) trypanosomes
were maintained in culture in HMI-9 [19]. For the microarray
study, to inactivate brucipain activity, the parasites were
pretreated for 30 min with 5 mM of the cathepsin-L inhibitor
K11777 The parasites were then washed with medium to remove
excess inhibitor prior to incubation with HBMEC monolayers
[9,10].
Electrical cell-substrate impedance sensing for real-time
transendothelial electrical resistance measurement and
cell signaling
The elevated transendothelial electrical resistance (TEER) and
the lower paracellular permeability of the brain microvasculature
is a characteristic feature that distinguishes it from non-brain
endothelium. Measurement of TEER is a one of the most
straightforward methods to access the barrier tightness using in vitro
models [20]. Electrical Cell-Substrate Impedance Sensing (ECIS)
gathers TEER data as an electrical method for assessing barrier
function that detect changes in endothelial cell shape in real-time
[21]. The Model 1600R ECIS system (Applied Biophysics)
[22,23,24] was used to measure HBMEC TEER changes in
real-time during exposure to African trypanosomes and their
secreted products. HBMECs were grown on collagen-coated 8-
well single (8W1E) or multiple (8W10E
+) gold electrode ECIS
arrays until confluent. While changes in relative TEER recorded
by the single and multiple arrays were similar, absolute TEER
values differ. Steady state TEER .10,000 ohms and .1,000 ohms
were used for the 8W1E and 8W10E
+ arrays respectively (Applied
Biophysics). The multiple electrode arrays in which HBMEC
resistances are .1,000 ohms [4,5,25,26] record the activities of
more cells over a larger region of the substrate. However, the 10-
fold lower capacitance of the 8W1E array leads to increased
resistances (more than 10 times that of the multiple electrode
arrays) and a higher signal to noise ratio (ECIS 1600R instruction
manual). Changes in resistance of HBMEC monolayers were
monitored every 80 sec in response to experimental variables. For
the PMT experiments, HBMECs were simultaneously incubated
with PMT (30 ng/ml) or pretreated with the toxin for 90 min then
washed with fresh medium prior to incubation with parasites.
HBMEC gene silencing by RNAi and analysis by laser
capture microdissection (LCM)
In single cell studies, when stimulated with PAR-2 agonists strong
Ca
2+ signals are induced ([15] in .60% of HBMEC (YV Kim,
unpublished) suggesting a role for PAR-2 in parasite HBMEC
traversal.Wesilencedthe F2RL1expressionbyco-transfectinga pre-
designed siRNA for F2RL1 and a GFP-expressing plasmid into
Author Summary
Human African trypanosomiasis, or sleeping sickness,
occurs when single-cell trypanosome protozoan parasites
spread from the blood to brain over the blood-brain
barrier (BBB). This barrier is composed of brain microvas-
cular endothelial cells (BMECs) especially designed to keep
pathogens out. Safe drugs for treating sleeping sickness
are lacking and alternative treatments are urgently
required. Using our human BMEC BBB model, we
previously found that a parasite protease, brucipain,
induced calcium activation signals that allowed this barrier
to open up to parasite crossing. Because human BMECs
express protease-activated receptors (PARs) that trigger
calcium signals in BMECs, we hypothesized a functional
link between parasite brucipain and BMEC PARs. Utilizing
RNA interference to block the production of one type of
PAR called PAR-2, we hindered the ability of trypanosomes
to both open up and cross human BMECs. Using gene-
profiling methods to interrogate candidate BMEC path-
ways specifically triggered by brucipain, several pathways
that potentially link brain inflammatory processes were
identified, a finding congruent with the known role of
PAR-2 as a mediator of inflammation. Overall, our data
support a role for brucipain and BMEC PARs in trypano-
some BBB transmigration, and as potential triggers for
brain inflammation associated with the disease.
Role of PAR in African Trypanosome BBB Interaction
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protocols. A matched negative control siRNA (Ambion) was used as
control. To determine the efficiency of gene silencing, HBMECs
were grown on 35 mm LCM dishes (PALM) prior to RNAi
silencing. Using laser capture microdissection (LCM), 15 individual
GFP-HBMECs that expressed GFP in the F2RL1-silenced and
control siRNA cultures were collected. The GFP-HBMECs were
marked and catapulted using the following settings on the P.A.L.M.
Microlaser (Bernied, Germany): energy-cut of 60; energy-lpc of 86;
focus-cut of 75 and focus-lpc of 92 [27]. The RNA extracted using
Ambion’s RNAqueousH-Micro kit was then amplified using
Ambion’s MessageAmp
TMII kit. qRT-PCR was done using pre-
designed F2RL1 primers (Invitrogen) and the data were normalized
to ACTB transcripts.
Co-incubation of HBMECs with trypanosomes
HBMECs grown to confluency in Transwell inserts, ECIS
arrays or 6-well microtiter plates were incubated at 37uCi n5 %
CO2 in Experimental Medium (HMI-9 and Medium 199 mixed
1:1) containing 10% FBS [5,9,10]. HBMEC were incubated in
triplicate with BSF T. b. rhodesiense IL1852 (5610
5 to 1610
6/ml)
under the indicated study conditions.
Transcriptome microarray analysis
Samples from 2 independent experiments containing duplicate
sets of infected (wild type or K11777 pretreated trypanosomes)
and uninfected HBMECs were rapidly dissociated with trypsin/
EDTA, than washed. Total cellular RNA was isolated using the
RNAeasy kit (QIAGEN) following the manufacturer’s instruc-
tions. Purified RNA was treated with RNase-free DNase to
remove contaminating genomic DNA. The integrity of RNA
transcripts was verified by electrophoresis through denaturing
agarose-formaldehyde gels followed by ethidium bromide
staining [28].
cDNAs were radiolabeled with
32P a-dCTP Isoblue (ICN) using
SuperScript II Reverse Transcriptase (Invitrogen). Unbound label
was separated using a Biospin P-30 spin column (Bio-Rad). Each
cDNA probe was adjusted to 10
6 cpm/mL and hybridized to
separate nylon MGC-1 microarrays [29] at 68uC overnight in
Microhyb hybridization solution (Research Genetics). The MGC-
1 microarray represents 9,600 different human gene features
including those encoding cytokines and other immunological
regulatory proteins such as chemokines, growth factors, and
cellular receptors [29]. Membranes were washed three times in
26SSC (16SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-1%
SDS for 30 min at 68uC and twice in 0.16 SSC-0.5% SDS for
30 min at 68uC. Membranes were exposed overnight and scanned
on a Molecular Dynamics STORM phosphoimager set to 50-
micron resolution. mRNA expression levels were analyzed by
scanning densitometry using ArrayPro imaging software. Differ-
ential patterns of gene expression were assessed by preparing RNA
from both uninfected control HBMEC or HBMEC that were co-
incubated with wild-type (WT) T. b. rhodesiense IL1852 or T. b.
rhodesiense K11777 inhibited for brucipain activity for 3 and
6 hours. These cDNAs were hybridized in parallel to pairs of
identical microarrays.
Raw microarray data were subjected to Z normalization and
tested for significant changes as previously described [30]. Genes
were determined to be differentially expressed after calculating the
Z ratio, which indicates the fold-difference between experimental
groups, and false discovery rate (fdr), which controls for the
expected proportion of falsely rejected hypotheses. Individual
genes with p value #0.05, absolute value of Z ratio.1.5 and
fdr,0.3 were considered significantly changed. Hierarchical
cluster method with complete algorithm and K-mean cluster were
employed to identify clustering within groups. Array data for each
experimental condition were hierarchically clustered with the
DIANE 6.0 software in JMP 6.0 environment and R programs.
Pilot studies showed no signal detected when trypanosome cDNA
was hybridized to the microarrays.
Probability scores for each network or functional Parametric
analysis of gene set enrichment (PAGE ) [31] gene set analysis was
performed by using the PAGE algorithm and PERL/R code with
MYSQL database. The archive of gene sets used with this
algorithm for this analysis is from the Molecular Signatures
Database (MSigDB) (http://www.broad.mit.edu/gsea/msigdb/
genesets.jsp?collection=CP) [32]. Significance of functions and
pathways was calculated using the z-test between each function
group genes and the genes in the whole sample. The p-value was
calculated by comparing the number of user-specified genes of
interest participating in a given function or pathway relative to the
total number of occurrences of these genes in all functional/
pathway annotations stored in the knowledge base. The
Figure 1. T. b. rhodesiense transmigration across HBMEC silenced for F2RL1 expression by RNAi. Using laser capture microdissection 15
individual HBMEC expressing GFP in the PAR2-silenced and control siRNA cultures were collected and the RNA extracted. (A) Based on qRT-PCR using
pre-designed F2RL1 primers and normalized to ACTB (b-actin transcripts), PAR-2 gene expression was reduced by over 95%. (B) T. b. rhodesiense
IL1852 was incubated for 16h in triplicate with HBMEC monolayers silenced for PAR-2 expression (F2RL1 siRNA), with a matched scrambled siRNA
control (control siRNA) construct, or with untreated HBMEC (no Rx control) and examined parasite transmigration.
doi:10.1371/journal.pntd.0000479.g001
Role of PAR in African Trypanosome BBB Interaction
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calculated by the difference of the mean z-ratio of the selected
function groups with the mean of z-ratio of the whole sample genes
to represent the pathway change altitude.
Array data from infected samples are presented as relative
changes to uninfected controls in mRNA expression following
normalization of gene signals to total signal and levels of
housekeeping gene mRNA to ensure analysis of equivalent
amounts of RNA. This approach facilitated the direct comparison
of mRNA levels between control and the parasite-treated
HBMEC.
Results/Discussion
The role of PAR-2 in trypanosome transmigration across
HBMECs
After silencing of F2RL1 by RNAi, based on qRT-PCR
targeting F2RL1 transcripts normalized to ACTB (b-actin tran-
scripts), we found that PAR-2 expression was reduced by over
95% (Fig 1A) in LCM-isolated HBMECs. To verify whether the
ability of T. b. rhodesiense to cross HBMECs requires host cell PAR-
2 signaling, we incubated T. b. rhodesiense IL1852 for 16h with
HBMEC monolayers silenced for F2RL1 expression (F2RL1
siRNA), transfected with a matched scrambled siRNA control
(control siRNA), or with untreated HBMECs (no Rx control)
(Fig 1B) and examined parasite transmigration. There was no
statistical difference in parasite transmigration between the 2
control samples: in medium alone and or medium with control
siRNA (p=0.077; 2-tail Student t-test). Considering a 95%
reduction in F2RL1 expression in the ,60% of the HBMEC that
express PAR-2, significant differences were observed between
F2RL1-silenced HBMECs compared to both control conditions:
39% inhibition (p=0.040) versus untreated HBMECs (no Rx
Figure 2. Real-time TEER changes in HBMEC silenced for PAR-2
gene expression. F2RL1 RNAi transfected HBMEC grown in 8W1E ECIS
chambers were incubated overnight with T. b. rhodesiense IL1852. The
changes in TEER relative to matched HBMEC control containing
scrambled siRNA construct (red line) and HBMEC silenced for F2RL1
(blue line) in the presence of parasites are shown.
doi:10.1371/journal.pntd.0000479.g002
Figure 3. PMT from Pasteurella multocida blocks T. b. rhodesiense induced changes in HBMEC TEER. HBMEC grown in 8W10E+ ECIS
chambers were incubated with T. b. rhodesiense IL1852. Shown are the changes in real-time TEER measured by ECIS. A) HBMECs incubated with T. b.
rhodesiense IL1852 in the absence (blue line) or continuous presence of PMT (30 ng/ml) (red line). B) HBMECs incubated with T. b. rhodesiense IL1852
was incubated with HBMECs untreated (blue line) or pretreated with PMT (30 ng/ml) (red line). The data are represented as the average change in
TEER6EM (n=3). The changes in TEER are represented as the average change in TEER6SEM (n=2).
doi:10.1371/journal.pntd.0000479.g003
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www.plosntds.org 4 July 2009 | Volume 3 | Issue 7 | e479Figure 4. Pathway changes altered by T. b. rhodesiense inhibited for brucipain activity. Significantly regulated, functional pathway clusters
were generated from wild-type (WT Tbr) T. b. rhodesiense or parasites K11777 inhibited for brucipain activity (KT Tbr) gene sets using PAGE gene set
analysis. Pathways that were significantly up-regulated (red) or down-regulated (green) are shown. Cluster group numbers are shown on the left,
while the grading scale is in the upper right.
doi:10.1371/journal.pntd.0000479.g004
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Time Pathway Name Cluster Annotation z-Score
3h 6h
After 3 h 1_2_DICHLOROETHANE_ DEGRADATION 1 [GenMAPP] 21.55 n.s.
ASCORBATE_AND_ALDARATE_ METABOLISM 1 [GenMAPP] 21.55 n.s.
CARM1_PATHWAY 1 The methyltransferase CARM1 interacts with transcription factors
such as CBP/p300 and methylates histones H3 and H4. [BioCarta]
21.10 n.s.
LEPTIN PATHWAY 1 Leptin is a peptide secreted by adipose tissue that, in skeletal
muscle, promotes fatty acid oxidation, decreases cells’ lipid content,
and promotes insulin sensitivity. [BioCarta]
21.04 n.s.
LIMONENE_AND_PINENE_ DEGRADATION 1 [GenMAPP] 21.47 n.s.
NUCLEOTIDE_GPCRS 1 [GenMAPP] 20.49 n.s.
CYSTEINE_METABOLISM 8 [GenMAPP] 1.89 n.s.
EIF2_PATHWAY 8 Eukaryotic initiation factor 2 (EIF2) initiates translation by transferring
Met-tRNA to the 40S ribosome in a GTP-dependent process. [BioCarta]
1.52 n.s.
ETC_PATHWAY 8 Energy is extracted from carbohydrates via oxidation and transferred to
the mitochondrial electron transport chain, which couples ATP synthesis
to the reduction of oxygen to water. [BioCarta]
1.74 n.s.
HBX_PATHWAY 8 Hbx is a hepatitis B protein that activates a number of transcription
factors, possibly by inducing calcium release from the mitochondrion
to the cytoplasm. [BioCarta]
0.83 n.s.
HCMV_PATHWAY 8 Cytomegalovirus activates MAP kinase pathways in the host cell,
inducing transcription of viral genes. [BioCarta]
1.18 n.s.
IL4_PATHWAY 8 IL4 promotes Th2 cell differentiation via a heterodimeric receptor
that activates Stat6/JAK and MAP kinase pathways. [BioCarta]
0.89 n.s.
SA_BONE_MORPHOGENETIC 8 Bone morphogenetic protein binds to its receptor to induce ectopic bone
formation and promote development of the viscera. [SigmaAldrich]
1.24 n.s.
SA_PTEN_PATHWAY 8 PTEN is a tumor suppressor that dephosphorylates the lipid messenger
phosphatidylinositol triphosphate. [SigmaAldrich]
0.90 n.s.
SIG_INSULIN_RECEPTOR_
PATHWAY_IN_CARDIAC_ MYOCYTES
8 Genes related to the insulin receptor pathway. [SIGNALINGAlliance] 1.98 n.s.
After 6 h BREAST_CANCER_ESTROGEN_SIGNALING 11 Genes preferentially expressed in breast cancers, especially those
involved in estrogen-receptor-dependent signal transduction. [GEArray]
n.s. 1.82
CLASSIC_PATHWAY 11 The classic complement pathway is initiated by antibodies and
promotes phagocytosis and lysis of foreign cells as well as
activating the inflammatory response. [BioCarta]
n.s. 2.62
IL7_PATHWAY 11 IL7 is required for B and T cell development and proliferation and may
contribute to activation of VDJ recombination. [BioCarta]
n.s. 2.05
PANTOTHENATE_AND_COA_ BIOSYNTHESIS 11 [GenMAPP] n.s. 2.27
CELL_2_CELL PATHWAY 15 Epithelial cell adhesion proteins such as cadherins transduce signals
into the cell via catenins, which alter cell shape and motility. [BioCarta]
n.s. 21.31
EPO_NFKB_PATHWAY 15 The cytokine erythropoietin (Epo) prevents stress-induced neuronal
apoptosis by stimulating anti-apoptotic pathways through JAK2
kinase and NFkB. [BioCarta]
n.s. 21.02
PHENYLALANINE_ METABOLISM 15 [GenMAPP] n.s. 21.52
RNA_TRANSCRIPTION_ REACTOME 15 [GenMAPP] n.s. 21.61
RNA_PATHWAY 15 dsRNA-activated protein kinase phosphorylates elF2a, which generally
inhibits translation, and activates NFkB to provoke inflammation. [BioCarta]
n.s. 21.69
SA_TRKA_RECEPTOR 15 The TrkA receptor binds nerve growth factor to activate MAP kinase
pathways and promote cell growth. [SigmaAldrich]
n.s. 21.84
ST_DICTYOSTELIUM_ DISCOIDEUM_CAMP_
CHEMOTAXIS_PATHWAY
15 The fungus Dictyostelium discoideum is a model system for cytoskeletal
organization during chemotaxis. [SIGNALING Transduction KE]
n.s. 22.04
ST_GA13_PATHWAY 15 G-alpha-13 influences the actin cytoskeleton and activates protein
kinase D, PI3K, and Pyk2. [SIGNALING Transduction KE]
n.s. 21.99
ST_GAQ_PATHWAY 15 G-alpha-q activates phospholipase C, resulting in calcium influx and
increasing protein kinase C activity. [SIGNALING Transduction KE]
n.s. 22.45
These gene sets are canonical representations of a biological process compiled by domain experts. PAGE gene set analysis was performed using the DIANE 6.0 software
using the PAGE algorithm. The archive of gene sets used with this algorithm for this analysis is from the MSigDB. Significance of functions and pathways was calculated
using the right-tailed Fisher’s Exact Test. The p-value was calculated by comparing the number of user-specified genes of interest participating in a given function or
pathway relative to the total number of occurrences of these genes in all functional/pathway annotations stored in the knowledge base.
n.s.: not significant
doi:10.1371/journal.pntd.0000479.t001
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treated HBMECs. In the absence of PAR-2-induced signaling, we
predicted that F2RL1-silenced primary HBMECs would maintain
a tighter barrier upon stimulation by T. b. rhodesiense. ECIS was
used to monitor real-time TEER changes in HBMEC monolayer
integrity. F2RL1 RNAi-transfected HBMECs grown in ECIS
chambers were incubated overnight with T. b. rhodesiense IL1852
(1.2610
6/mL). Fig 2 shows that unlike the matched HBMEC
scrambled siRNA control (red line), HBMECs silenced for PAR-2
maintained control TEER levels (about 10,000 ohms in the 8W1E
arrays used) (blue line) for at least 20 hours even in the presence of
a high parasite load.
The Ga-specific toxin from Pasteurella multocida blocks
trypanosome-induced changes in TEER in HBMEC
PARs, including PAR-2, are GPCRs known to mediate their
cellular effects through the activation of Gaq/11,G a12/13 and
Gaibc signaling pathways [33,34,35,36]. The protein toxin from
Pasteurella multocida (PMT) has been shown to target Gaq
[37,38,39], Ga12/13 [40] and Gai [41] heterotrimeric G proteins
in eukaryotic cells. PMT potentiates Gaq protein-mediated GPCR
responses to ligands by primarily activating phospholipase C (i.e.
PLC-b1, 3, 4) [37,38,39,42]. Accordingly, this leads to calcium
mobilization and activation of PKCs, as well as activation of
mitogenic pathways, including MAPK (ERK1/2, p38) activation
[39,42,43]. PMT enters cells via receptor-mediated endocytosis
and acts intracellularly to activate Gaq [37,38,39,44]. This is
subsequently followed by uncoupling of Gaq signaling when
cellular Gaq-mediated responses then become refractory to further
stimulation [45,46]. This also occurs when HBMECs are
incubated with PMT. As shown in Fig. 3A, when incubated
together with HBMECs and T. b. rhodesiense, PMT (30 ng/ml)
initially does not inhibit the parasite-induced drop in TEER by
ECIS. However, TEER increases above control levels with
parasites after 2 hours, consistent with uncoupling of Gaq
signaling by PMT. When HBMECs are pretreated for 3h with
PMT to allow for Gaq uncoupling prior to trypanosome addition,
the toxin clearly inhibited the ability of the parasites to
compromise the HBMEC monolayers (Fig 3B). Since PAR-2 is a
GPCR that can act via Gaq signaling, taken together, the data
strongly suggest a role for PAR-2 and host Gaq-mediated calcium
signaling in parasite interactions with the human BBB. While not
yet tested would it be interesting to see the effect of PMT
treatment on PAR-2 RNAi treated cells; i.e. are there additive
effects of PMT treatment in these cells or is the PMT effect
occluded by PAR-2 knockdown.
Gene expression pathways in HBMEC in response to
African trypanosomes lacking brucipain activity
PAR-2 signaling has been shown in other systems to have
neuroinflammatory and neuroprotective roles [47,48,49,50] and
our data implicate a role for brucipain and PAR-2 in African
trypanosome/HBMEC interactions. Therefore, we used tran-
scription-profiling methods to interrogate candidate HBMEC
pathways with particular attention paid to pathways that are
specifically triggered by brucipain and that potentially link cellular
processes to physiologic (i.e. CNS passage across the BBB) and
pathophysiologic (neuroinflammation) processes associated with
Table 2. Functional overview of significant categorized MSigDB gene sets based on the pathways altered by both wild-type and T.
b. rhodesiense inhibited for brucipain activity.
Cytokines
Transcription
Factors
Cell Surface
Markers Kinases
Translocated
Genes Oncogenes
Tumor
Suppressors
Tumor suppressors TP53 CDKN2A, CFL1,
PTEN, TP53
Oncogenes CDK4, RAF1 CCND1 CCND1, CDK4,
HRAS, MDM2,
PTPN1, RAF1
Translocated genes NFKB2 TRFC LCK CCND1, LCK, NFKB2,
TRFC
Kinases ACTR2, CAMK2B,
CDK2, CDK4, FYN,
LCK, MAP2K2,
MAP3K3P,PAK4,
RAF1, RPS6KA1,
RPS6KA2,
RPS6KB2
Cell surface Markers CD38, TRFC
Transcription factors ERCC3, GATA3,
GTF2F1, HDAC1,
HMGB1, KLF5,
MEF2A, MEF2B,
MYOD1, NFATC3,
NFKB2, NFKBIB,
NFKBIE, NFYB, NROB,
NR1H3, RELA, STAT1,
TAF6, TAF9, TP53
Cytokines IFNGR1, IFNGR2,
IL2RG, IL6
A functional overview of the MSigDB gene sets categorized into a small number of selected gene families whose members a common feature such as homology or
biochemical activity. They do not necessarily have common origins. Annotation of pathway genes significantly expressed in HBMEC only in response to T. b. rhodesiense
inhibited for brucipain activity are shown in bold font.
doi:10.1371/journal.pntd.0000479.t002
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www.plosntds.org 7 July 2009 | Volume 3 | Issue 7 | e479Table 3. Annotation of pathway genes significantly expressed in HBMEC only in response to T. b. rhodesiense inhibited for
brucipain activity.
Gene Family
[MSigDB] Symbol
MsigDB
Accession No. Gene Names GO Definitions z-Ratio
3h 6h
cytokine IFNGR2 BC003624 interferon gamma receptor 2
(interferon gamma transducer 1)
cell surface receptor linked signal
transduction
0.81 n.s.
integral to plasma membrane
antiviral response protein activity
cytokine IL2RG BC014972 interleukin 2 receptor, gamma
(severe combined
immunodeficiency)
cell proliferation n.s. 1.12
integral to plasma membrane
interleukin-2 receptor activity
cytokine IL6 BC015511 interleukin 6 (interferon, beta 2) acute-phase response n.s. 0.84
extracellular space
IL-6 receptor ligand activity
kinase CAMK2B BC019070 calcium/calmodulin-dependent
protein kinase (CaM kinase) II beta
protein amino acid phosphorylation 0.80 n.s.
ATP binding activity
kinase CDK2 BC003065 cyclin-dependent kinase 2 G2/M transition of mitotic cell cycle 0.75 n.s.
cytoplasm
ATP binding activity
kinase MAP2K2 BC000471 mitogen-activated protein kinase
kinase 2
protein amino acid phosphorylation 1.98 n.s.
extracellular
ATP binding activity
kinase PAK4 BC002921 p21(CDKN1A)-activated kinase 4 cell motility 21.25 n.s.
Golgi apparatus
ATP binding activity
kinase RPS6KA2 BC002363 ribosomal protein S6 kinase,
90kDa, polypeptide 2
protein amino acid phosphorylation 1.36 n.s.
nucleus
ATP binding activity
kinase RPS6KB2 BC000094 ribosomal protein S6 kinase,
70kDa, polypeptide 2
protein amino acid phosphorylation 1.46 n.s.
ATP binding activity
kinase, translocated
gene
LCK BC013200 lymphocyte-specific protein
tyrosine kinase
RAS protein signal transduction n.s. 1.65
membrane fraction
ATP binding activity
oncogene MDM2 BC009893 Mdm2, transformed 3T3 cell
double minute 2, p53 binding
protein (mouse)
negative regulation of cell proliferation 21.69 n.s.
nucleus
ligase activity
oncogene PTPN1 BC015660 protein tyrosine phosphatase,
non-receptor type 1
protein amino acid dephosphorylation 0.66 n.s.
cytoplasm
prenylated protein tyrosine phosphatase
activity
oncogene, kinase CDK4 BC010153 cyclin-dependent kinase 4 G1/S transition of mitotic cell cycle 1.11 n.s.
ATP binding activity
oncogene,
translocated gene
CCND1 BC014078 cyclin D1 (PRAD1: parathyroid
adenomatosis 1)
G1/S transition of mitotic cell cycle 21.13 n.s.
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[MSigDB] Symbol
MsigDB
Accession No. Gene Names GO Definitions z-Ratio
3h 6h
cellular_component unknown
transcription factor ACTR2 BC014546 ARP2 actin-related protein 2
homolog (yeast)
cell motility 21.58 n.s.
Arp2/3 protein complex
structural constituent of cytoskeleton
transcription factor ERCC3 BC008820 excision repair cross-
complementing rodent repair
deficiency, complementation
group 3 (xeroderma pigmentosum
group B complementing)
regulation of transcription\, DNA-
dependent nucleus ATP dependent
DNA helicase activity
21.62 n.s.
transcription factor FYN NM_002037 FYN oncogene related to
SRC, FGR, YES
cell growth and/or maintenance ATP
binding activity
20.36 0.61
transcription factor GATA3 BC006793 GATA binding protein 3 defense response (activates Th2 cytokine
gene expression) nucleus transcription
factor activity
1.44 n.s.
transcription factor GTF2F1 BC000120 general transcription factor IIF,
polypeptide 1, 74kDa
regulation of transcription\,
DNA-dependent
n.s. 0.77
transcription factor TFIIF complex
DNA binding activity
transcription factor HMGB1 BC003378 high-mobility group box 1 DNA unwinding 0.97 n.s.
chromatin
single-stranded DNA binding activity
transcription factor MEF2A BC013437 MADS box transcription
enhancer factor 2, polypeptide
A (myocyte enhancer factor 2A)
muscle development 21.34 n.s.
nucleus
transcription co-activator activity
transcription factor MYOD1 BC000353 myogenic factor 3 cell differentiation 1.86 n.s.
nucleus
RNA polymerase II transcription factor
activity\, enhancer binding
transcription factor NFATC3 BC001050 nuclear factor of activated
T-cells, cytoplasmic, calcineurin-
dependent 3
inflammatory response 20.90 n.s.
nucleus
transcription co-activator activity
transcription factor NFKBIE BC011676 nuclear factor of kappa light
polypeptide gene enhancer in
B-cells inhibitor, epsilon
cytoplasm 1.79 n.s.
transcription factor binding activity\,
cytoplasmic sequestering
transcription factor NFYB BC005316 nuclear transcription factor Y,
beta
regulation of transcription\,
DNA-dependent
0.82 n.s.
nucleus
transcription factor activity
transcription factor NR1H3 BC008819 nuclear receptor subfamily 1,
group H, member 3
regulation of transcription\,
DNA-dependent
20.94 n.s.
nucleus
steroid hormone receptor activity
transcription factor RELA BC014095 v-rel reticuloendotheliosis viral
oncogene homolog A, nuclear
factor of kappa light polypeptide
gene enhancer in B-cells 3, p65
(avian)
anti-apoptosis 1.40 n.s.
transcription factor complex
protein binding activity
Table 3. Cont.
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pretreatment with K11777 (a cell-permeable class-specific irre-
versible inhibitor of brucipain) are defective in crossing HBMECs
[5,9,10,16,17]. We interrogated candidate HBMEC pathways
whose expression was modulated by exposure to T. b. rhodesiense
pretreated with the brucipain inhibitor K11777. Because the half-
life of brucipain is not known, the experimental time frame was
kept to 6 hours, the approximate doubling time of the parasite.
This was done to minimize the potential problems in data
interpretation because of the contribution of decreasing drug
within the parasites that were doubling.
Gene set enrichment analysis of HBMEC based on the known
canonical pathways showed that WT and modified African
trypanosomes differentially altered the expression of genes
represented in 99 pathways relative to the uninfected controls
(Fig 4; Table 1). While the 99 pathways clustered into 15 groups
according to their gene expression profiles, 28 pathways clustered
into 4 unique cluster groups that were specifically expressed by
HBMECs only after exposure to the K11777-pretreated trypano-
somes (Table 1). A functional overview of the MSigDB gene sets
was then done to categorize a small number of selected ‘‘gene
families’’ whose members shared a common feature such as
homology or biochemical activity, although not necessarily having
common origins. Analysis of the gene functions within the
HBMEC pathways showed 47 genes differentially expressed by
HBMECs in response to trypanosome infection (Table 2). From
this gene subset, 30 genes were expressed exclusively by HBMEC
in response to brucipain-inhibited parasites (Tables 2 and 3). Of
these, 30 genes functionally i) 3 encoded cytokines, ii) 16 encoded
transcription factors, iii) 8 encoded kinases, iv) 3 encoded for
translocated genes, and v) 4 encoded for oncogenes. Interestingly,
HBMEC genes encoding for cell surface markers and tumor
suppressors in response to wild-type trypanosomes, were not
expressed by brucipain-inhibited parasites (Table 2).
Analysis of the HBMEC pathways specifically altered by the
brucipain-inhibited parasites included those found only within
down-regulated Clusters-1 and Cluster-15, or up-regulated
Cluster-8 and Cluster-11. Cluster-1 consisted of 6 different
pathways that had negative Z-score values (and were therefore
positively effected by brucipain) by 3-hours, and that returned to
control levels by 6h (Figure 4, Table 1). While roles for the
metabolic/degradation pathways in Cluster-1 in HAT are not
clear, the data suggest brucipain alters the CARM1 and Leptin
pathways. Leptin is a protein hormone typically produced by
adipose tissue that is known to regulate appetite via binding to the
leptin receptor (LEPR) in the hypothalamus after crossing the BBB
[51,52]. It has been suggested that compromised leptin transport
into the CNS resulting in low leptin levels in the hippocampus
could lead to cognitive deficits [53]. There is evidence that the
secretion of photoperiodic hormones such as melatonin is inversely
regulated by leptin [54]. It is also tempting to speculate a role for
leptin in HAT considering that disturbance in the circadian
rhythm of the melatonin-generating systems in the pathogenesis of
African sleeping sickness has been demonstrated [55].
Brucipain may also alter processes linked to arginine methyl-
ation. CARM1 is a protein arginine N-methlytransferase that
plays a role in protein arginine methylation, a process that is
implicated in signal transduction, nascent pre-RNA metabolism
and transcriptional activation [56]. These data suggest that
CARM1, as a promoter-specific regulator of NF-kB-dependent
gene expression [57], could play a role in the inflammatory
responses associated with CNS HAT.
In contrast to the Cluster-1 pathways, 3 hours exposure to the
brucipain-inhibited trypanosomes upregulated 9 pathways repre-
sented in Cluster-8 (Figure 1, Table 1). Inhibiting brucipain
activity appeared to activate the eukaryotic initiation factor-2
(EIF2)-pathway. EIF2 binding to GTP and Met-tRNA would in
turn initiate translation by transferring the Met-tRNA to the 40S
ribosomal subunit. If brucipain plays a role in downregulating this
pathway, the event could shut-down cellular protein synthesis and
could have consequences to overall cell viability [58].
The response to activation of PAR-2 is the elevation of
intracellular Ca
2+ via the PLC/IP3 pathway [59,60], which leads
to downstream increases in intracellular Ca
2+, activation of PKC,
Gene Family
[MSigDB] Symbol
MsigDB
Accession No. Gene Names GO Definitions z-Ratio
3h 6h
transcription factor TAF6 BC018115 TAF6 RNA polymerase II, TATA
box binding protein (TBP)-
associated factor, 80kDa
regulation of transcription\,
DNA-dependent
1.18 n.s.
transcription factor TFIID complex
DNA binding activity
transcription factor TAF9 BC007349 TAF9 RNA polymerase II, TATA
box binding protein (TBP)-
associated factor, 32kDa
regulation of transcription\,
DNA-dependent
0.51 n.s.
transcription factor TFIID complex
DNA binding activity
translocated gene,
transcription factor
NFKB2 BC002844 nuclear factor of kappa light
polypeptide gene enhancer
in B-cells 2 (p49/p100)
cell growth and/or maintenance 22.37 n.s.
nucleus
transcription co-activator activity
Raw microarray data were subjected to Z normalization and tested for significant changes. Genes were determined to be differentially expressed after calculating the Z
ratio and fdr.
n.s.: not significant
doi:10.1371/journal.pntd.0000479.t003
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protein kinases [61,62,63]. It has been also shown in other systems
that direct PAR-2 activation of extracellular signal-regulated
kinase (ERK) subfamily of MAPK [64] may be neuroprotective
[47,48,49]. Because of the above characteristics associated with
PAR-2 activation, it is remarkable that the most dramatic changes
that happened between 3 and 6 hours in the pathways were
associated with Cluster-11 and Cluster-15 (Table 1). Cluster-11
contained 4 pathways with strong positive Z-scores in response to
the brucipain-inhibited trypanosomes. Of these 4 pathways, 3
were involved either with cell signaling (BREAST_CANCER_-
ESTROGEN_SIGNALING) or inflammatory responses (CLAS-
SIC_PATHWAY, IL7_PATHWAY). In contrast to Cluster 11, all
pathways in Cluster 15 displayed negative Z-scores, indicating
downregulation. In some respects, Cluster 15 is the most
interesting as it contained pathways that conceivably play a role
in parasite transmigration of the BBB as an early event, and in the
subsequent later inflammatory responses associated with HAT.
The involvement of the ST_GAQ_PATHWAY (Fig. 4, Table 1) is
interesting given that calcium signaling may play an important
role in trypanosome / BBB associated events. Furthermore, the
changes in the ST_GA13- SA_TRKA_RECEPTOR, ST_DIC-
TOYOSTELIUM_DISCOIDEUM_CAMP_CHEMOTAXIS,
and CELL_2_CELL-pathways also parallel roles for PI3K,
MAPK and cell cytoskeleton. A role for brucipain as an inducer
of inflammatory responses [4] is also predicted (i.e.,
EPO_NFKB_PATHWAY, RNA_PATHWAY).
Conclusions
We studied parasite proteases in the interaction of T. b.
rhodesiense w i t hH B M E C s .O v e r a l l ,o u rR N A i ,P M Ta n dD N A -
microarray data support an important role for brucipain,
HBMEC PAR-2 (and possibly other PARs) and Gq signaling
for trypanosome transmigration across the BBB. Owing to PAR-
2’s role in neuroinflammation, these data also suggest a role for
this GPCR in CNS HAT. In murine models of HAT the
neuroinflammatory response [1,65] is likely a balance between
pro-inflammatory cytokines such as interferon-c (IFN-c), inter-
leukin-1(IL-1) and tumour necrosis factor-a (TNF-a), and
counter-inflammatory cytokines such as IL-10 [66]. A role for
cytokines in determining entry of trypanosomes into the CNS
was provided by a seminal study in knockout mice in which the
gene for IFN-c had been disrupted [67]. Following systemic
infection, it was found that trypanosomes accumulated in the
perivascular regions, ‘trapped’ between the endothelial and the
parenchymal basement membranes. While these findings
suggested that lymphocyte-derived IFN-c is required for
trypanosome traversal across cerebral blood vessels [67],
precisely how IFN-c facilitates BBB traversal by the parasites
has yet to be determined. Interestingly, minocycline, a
tetracycline antibiotic, was also found to impede the penetration
of leukocytes and trypanosomes into the brain parenchyma [68].
It is tempting to speculate a role for PAR-2 in these processes. It
has been shown that the inflammatory response in mouse colonic
tissue mediated by PAR-2 activation (using PAR-2 agonists) that
leads to i) increased tissue permeability, ii) increased IFN-c and
TNF-a expression, and iv) decreased IL-10 expression, are
abolished in IFN-c deficient B6 mice [69]. More recently,
minocycline has been shown to block the PAR-2-mediated TNF-
a-induced production of IL-8 proinflammatory response in
epidermal keratinocytes (Ishikawa) [70].
Our previous work strongly suggested that T. b. rhodesiense
crosses the human BBB by generating Ca
2+ activation signals in
HBMECs through the activity of parasite cysteine proteases [5,9].
Using T. b. brucei silenced for (RNAi) it was later found that
parasite cathepsin L (brucipain) could be the parasite factor
initiating transmigration and increased vascular permeability [11].
While a singular role has not been established for this process of
parasite transmigration in vivo, GPCR PAR2 is one of the
molecular targets for brucipain as an activator of Gq-mediated
calcium-signaling involving the downstream effectors PLC and
PKC [5,9]. The in vivo consequence of these events, similar to our
in vitro findings, is predicted to be increased permeability of the
BBB to parasite transmigration, an event precursory to CNS
Figure 5. Proposed model for African trypanosome-induced
BBB dysfunction. We hypothesize that parasite proteases trigger
GPCRs (i.e. PARs?) via Gaq activation, which leads to PLC-mediated Ca
2+
release from intracellular stores. The increase in intracellular calcium
leads to calmodulin (CaM) activation of myosin light chain kinase
(MLCK), ultimately leading to cytoskeletal changes and barrier
dysfunction. Ca
2+-independent activation of the cytoskeleton mediated
by Ras-superfamily GTPases (i.e. RhoA) is also possible via p63RhoGEF.
Parasite and/or host-derived proteases may also contribute by
degrading or altering adherens junction (AJ) and tight junction (TJ)
proteins.
doi:10.1371/journal.pntd.0000479.g005
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for this protein as an attractive drug or vaccine target.
Based on our published and findings reported here [4,5,9,10],
we hypothesize that African trypanosome-mediated BBB dysfunc-
tion is linked to the interactions of parasite and/or parasite
protease activity with BMEC GPCRs (i.e. PARs) (Fig. 5).
Activation of downstream effectors then enable African trypano-
some transmigration through the BBB after cytoskeletal rear-
rangements that induce cell retraction and loosening of junctional
complexes. We predict that trypanosomes/parasite/proteases
trigger Gaq activation of PLC-b, in turn generating inositol-
1,4,5-triphosphate (IP3) and diacylglycerol (DAG) from phospha-
tidylinositol-4,5-bisphosphate (PIP2). Binding of IP3 to its receptor
on the endoplasmic reticulum releases Ca
2+ from intracellular
stores. The increase in intracellular calcium leads to calmodulin
(CaM) activation of myosin light chain (MLC) kinase (MLCK)
and/or other effectors ultimately leading to cytoskeletal changes
and barrier dysfunction. Ca
2+-independent activation of the
cytoskeleton by Ras-superfamily GTPases (i.e RhoA) traditionally
by Ga12/13 GPCRs, is also possible via Gaq activation of
p63RhoGEF [42,71]. Although not yet determined, parasite
and/or host-derived proteases may also contribute by degrading
or altering adherens junction (AJ) and tight junction (TJ) proteins.
Clearly, a study on the contribution of the products of gene
expression identified with the biochemical pathways needs to be
investigated as well as testing using established animal models of
HAT [4]. An understanding of these responses at a molecular level
will help identify candidates for the early diagnosis, treatment, and
prevention of CNS invasion with HAT.
Acknowledgments
The authors wish to thank Dr. J. McKerrow and Dr. Maha Abdulla,
University of California San Francisco, for providing K11777 and for
critical reading of the manuscript. We also thank Joseph Crompton, Emily
Clemens, Donna Pearce and Nicole Barat for expert technical assistance,
and Applied Biophysics (Troy, NY) for loan of a 1600R ECIS instrument.
DJG dedicates this work in remembrance of Justina Brincko.
Author Contributions
Conceived and designed the experiments: DJG JCGG YVK CAP KGB
BAW APCdAL JS JSD. Performed the experiments: DJG JCGG OVN
AB. Analyzed the data: DJG JCGG OVN YZ KGB JSD. Contributed
reagents/materials/analysis tools: DJG BAW APCdAL. Wrote the paper:
DJG JCGG JSD.
References
1. Kennedy PG (2004) Human African trypanosomiasis of the CNS: current issues
and challenges. J Clin Invest 113: 496–504.
2. Molyneux DH, Pentreath V, Doua F (1996) African trypanosomiasis in man.
London: Saunders WB. pp 1171–1196.
3. Rogers DJ, Williams BG (1993) Monitoring trypanosomiasis in space and time.
Parasitology 106 Suppl: S77–92.
4. Grab DJ, Kennedy PE (2008) Traversal of human and animal trypanosomes
across the blood-brain barrier. J Neurovirology 14: 344–351.
5. Grab DJ, Nikolskaia O, Kim YV, Lonsdale-Eccles JD, Ito S, et al. (2004) African
trypanosome interactions with an in vitro model of the human blood-brain
barrier. J Parasitol 90: 970–979.
6. Lonsdale-Eccles JD, Grab DJ (2002) Trypanosome hydrolases and the blood-
brain barrier. Trends Parasitol 18: 17–19.
7. Mackey ZB, O’Brien TC, Greenbaum DC, Blank RB, McKerrow JH (2004) A
cathepsin B-like protease is required for host protein degradation in Trypanosoma
brucei. J Biol Chem 279: 48426–48433.
8. Scory S, Caffrey CR, Stierhof YD, Ruppel A, Steverding D (1999) Trypanosoma
brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase
inhibitor Z-phe-ala-CHN2. Exp Parasitol 91: 327–333.
9. Nikolskaia OV, Lima APCA, Kim YV, Lonsdale-Eccles JD, Fukuma T, et al.
(2006) Blood-brain barrier traversal by African trypanosomes requires calcium
signaling induced by parasite cysteine protease. J Clin Invest 116: 2739–2747.
10. Nikolskaia OV, de ALAP, Kim YV, Lonsdale-Eccles JD, Fukuma T, et al. (2008)
Erratum. J Clin Invest 118: 1974.
11. Abdulla MH, O’Brien T, Mackey ZB, Sajid M, Grab DJ, et al. (2008) RNA
Interference of Trypanosoma brucei Cathepsin B and L Affects Disease Progression
in a Mouse Model. PLoS Negl Trop Dis 2: e298.
12. Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, et al. (2001)
Activation of protease-activated receptors by gingipains from Porphyromonas
gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity.
Blood 97: 3790–3797.
13. Lourbakos A, Potempa J, Travis J, D’Andrea MR, Andrade-Gordon P, et al.
(2001) Arginine-specific protease from Porphyromonas gingivalis activates protease-
activated receptors on human oral epithelial cells and induces interleukin-6
secretion. Infect Immun 69: 5121–5130.
14. Lourbakos A, Chinni C, Thompson P, Potempa J, Travis J, et al. (1998)
Cleavage and activation of proteinase-activated receptor-2 on human neutro-
phils by gingipain-R from Porphyromonas gingivalis. FEBS Lett 435: 45–48.
15. Kim YV, Di Cello F, Hillaire CS, Kim KS (2004) Differential Ca
2+ signaling by
thrombin and protease-activated receptor-1-activating peptide in human brain
microvascular endothelial cells. Am J Physiol Cell Physiol 286: C31–42.
16. Palmer JT, Rasnick D, Klaus JL, Bromme D (1995) Vinyl sulfones as
mechanism-based cysteine protease inhibitors. J Med Chem 38: 3193–3196.
17. Doyle PS, Zhou YM, Engel JC, McKerrow JH (2007) A cysteine protease
inhibitor cures Chagas’ disease in an immunodeficient-mouse model of infection.
Antimicrob Agents Chemother 51: 3932–3939.
18. Aminova LR, Wilson BA (2007) Calcineurin-independent inhibition of 3T3-L1
adipogenesis by Pasteurella multocida toxin: suppression of Notch1, stabilization of
beta-catenin and pre-adipocyte factor 1. Cell Microbiol 9: 2485–2496.
19. Hirumi H, Hirumi K (1989) Continuous cultivation of Trypanosoma brucei blood
stream forms in a medium containing a low concentration of serum protein
without feeder cell layers. J Parasitol 75: 985–989.
20. Deli MA, Abraham CS, Kataoka Y, Niwa M (2005) Permeability studies on in
vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell
Mol Neurobiol 25: 59–127.
21. Tiruppathi C, Malik AB, Del Vecchio PJ, Keese CR, Giaever I (1992) Electrical
method for detection of endothelial cell shape change in real time: assessment of
endothelial barrier function. Proc Natl Acad Sci U S A 89: 7919–7923.
22. Aschner M, Vitarella D, Allen JW, Conklin DR, Cowan KS (1998)
Methylmercury-induced astrocytic swelling is associated with activation of
the Na+/H+ antiporter, and is fully reversed by amiloride. Brain Res 799:
207–214.
23. Reddy L, Wang HS, Keese CR, Giaever I, Smith TJ (1998) Assessment of rapid
morphological changes associated with elevated cAMP levels in human orbital
fibroblasts. Exp Cell Res 245: 360–367.
24. Keese C (2001) Monitoring of cells during signal transduction. Genetic
Engineering News 21: 51.
25. Grab DJ, Perides G, Dumler JS, Kim KJ, Park J, et al. (2005) Borrelia burgdorferi,
host-derived proteases, and the blood-brain barrier. Infect Immun 73:
1014–1022.
26. Nyarko E, Grab DJ, Dumler JS (2006) Anaplasma phagocytophilum-infected
neutrophils enhance transmigration of Borrelia burgdorferi across the human blood
brain barrier in vitro. Int J Parasitol 36: 601–605.
27. Brown A, Zhang H, Lopez P, Pardo CA, Gartner S (2006) In vitro modeling of
the HIV-macrophage reservoir. J Leukoc Biol 80: 1127–1135.
28. Eckmann L, Smith JR, Housley MP, Dwinell MB, Kagnoff MF (2000) Analysis
by high density cDNA arrays of altered gene expression in human intestinal
epithelial cells in response to infection with the invasive enteric bacteria
Salmonella. J Biol Chem 275: 14084–14094.
29. Nadon NL, Mohr D, Becker KG (2005) National Institute on Aging microarray
facility--resources for gerontology research. J Gerontol A Biol Sci Med Sci 60:
413–415.
30. Cheadle C, Vawter MP, Freed WJ, Becker KG (2003) Analysis of microarray
data using Z score transformation. J Mol Diagn 5: 73–81.
31. Kim SY, Volsky DJ (2005) PAGE: parametric analysis of gene set enrichment.
BMC Bioinformatics 6: 144.
32. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005)
Gene set enrichment analysis: a knowledge-based approach for interpreting
genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545–15550.
33. Vaidyula VR, Rao AK (2003) Role of Galphaq and phospholipase C-beta2 in
human platelets activation by thrombin receptors PAR1 and PAR4: studies in
human platelets deficient in Galphaq and phospholipase C-beta2. Br J Haematol
121: 491–496.
34. Offermanns S, Toombs CF, Hu YH, Simon MI (1997) Defective platelet
activation in G alpha(q)-deficient mice. Nature 389: 183–186.
35. Offermanns S, Laugwitz KL, Spicher K, Schultz G (1994) G proteins of the G12
family are activated via thromboxane A2 and thrombin receptors in human
platelets. Proc Natl Acad Sci U S A 91: 504–508.
Role of PAR in African Trypanosome BBB Interaction
www.plosntds.org 12 July 2009 | Volume 3 | Issue 7 | e47936. Babich M, King KL, Nissenson RA (1990) Thrombin stimulates inositol
phosphate production and intracellular free calcium by a pertussis toxin-
insensitive mechanism in osteosarcoma cells. Endocrinology 126: 948–954.
37. Zywietz A, Gohla A, Schmelz M, Schultz G, Offermanns S (2001) Pleiotropic
effects of Pasteurella multocida toxin are mediated by Gq-dependent and -
independent mechanisms. Involvement of Gq but not G11. J Biol Chem 276:
3840–3845.
38. Wilson BA, Ho M (2004) Pasteurella multocida toxin as a tool for studying Gq
signal transduction. Rev Physiol Biochem Pharmacol 152: 93–109.
39. Aminova LR, Luo S, Bannai Y, Ho M, Wilson BA (2008) The C3 domain of
Pasteurella multocida toxin is the minimal domain responsible for activation of
Gq-dependent calcium and mitogenic signaling. Protein Sci 17: 945–949.
40. Orth JH, Lang S, Taniguchi M, Aktories K (2005) Pasteurella multocida toxin-
induced activation of RhoA is mediated via two families of G{alpha} proteins,
G{alpha}q and G{alpha}12/13. J Biol Chem 280: 36701–36707.
41. Orth JH, Fester I, Preuss I, Agnoletto L, Wilson BA, et al. (2008) Activation of
Galpha (i) and subsequent uncoupling of receptor-Galpha(i) signaling by
Pasteurella multocida toxin. J Biol Chem 283: 23288–23294.
42. Mizuno N, Itoh H (2009) Functions and regulatory mechanisms of Gq-signaling
pathways. Neurosignals 17: 42–54.
43. Seo B, Choy EW, Maudsley S, Miller WE, Wilson BA, et al. (2000) Pasteurella
multocida toxin stimulates mitogen-activated protein kinase via G(q/11)-
dependent transactivation of the epidermal growth factor receptor. J Biol Chem
275: 2239–2245.
44. Orth JH, Lang S, Aktories K (2004) Action of Pasteurella multocida toxin depends
on the helical domain of Galphaq. J Biol Chem 279: 34150–34155.
45. Wilson BA, Aminova LR, Ponferrada VG, Ho M (2000) Differential modulation
and subsequent blockade of mitogenic signaling and cell cycle progression by
Pasteurella multocida toxin. Infect Immun 68: 4531–4538.
46. Wilson BA, Zhu X, Ho M, Lu L (1997) Pasteurella multocida toxin activates the
inositol triphosphate signaling pathway in Xenopus oocytes via G(q)alpha-
coupled phospholipase C-beta1. J Biol Chem 272: 1268–1275.
47. Mocchetti I, Bachis A (2004) Brain-derived neurotrophic factor activation of
TrkB protects neurons from HIV-1/gp120-induced cell death. Crit Rev
Neurobiol 16: 51–57.
48. Li F, Omori N, Jin G, Wang SJ, Sato K, et al. (2003) Cooperative expression of
survival p-ERK and p-Akt signals in rat brain neurons after transient MCAO.
Brain Res 962: 21–26.
49. Hetman M, Xia Z (2000) Signaling pathways mediating anti-apoptotic action of
neurotrophins. Acta Neurobiol Exp (Wars) 60: 531–545.
50. Bushell T (2007) The emergence of proteinase-activated receptor-2 as a novel
target for the treatment of inflammation-related CNS disorders. J Physiol 581:
7–16.
51. Pan W, Hsuchou H, Tu H, Kastin AJ (2008) Developmental changes of leptin
receptors in cerebral microvessels: unexpected relation to leptin transport.
Endocrinology 149: 877–885.
52. Otvos L Jr, Terrasi M, Cascio S, Cassone M, Abbadessa G, et al. (2008)
Development of a pharmacologically improved peptide agonist of the leptin
receptor. Biochim Biophys Acta 1783: 1745–1754.
53. Farr SA, Banks WA, Morley JE (2006) Effects of leptin on memory processing.
Peptides 27: 1420–1425.
54. Zieba DA, Szczesna M, Klocek-Gorka B, Molik E, Misztal T, et al. (2008)
Seasonal effects of central leptin infusion on secretion of melatonin and prolactin
and on SOCS-3 gene expression in ewes. J Endocrinol 198: 147–155.
55. Kristensson K, Claustrat B, Mhlanga JD, Moller M (1998) African trypanoso-
miasis in the rat alters melatonin secretion and melatonin receptor binding in the
suprachiasmatic nucleus. Brain Res Bull 47: 265–269.
56. Frankel A, Yadav N, Lee J, Branscombe TL, Clarke S, et al. (2002) The novel
human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme
displaying unique substrate specificity. J Biol Chem 277: 3537–3543.
57. Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, et al. (2005) Arginine
methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-
dependent gene expression. EMBO J 24: 85–96.
58. Girard M, Bisser S, Courtioux B, Vermot-Desroches C, Bouteille B, et al. (2003)
In vitro induction of microglial and endothelial cell apoptosis by cerebrospinal
fluids from patients with human African trypanosomiasis. Int J Parasitol 33:
713–720.
59. Bushell TJ, Plevin R, Cobb S, Irving AJ (2006) Characterization of proteinase-
activated receptor 2 signalling and expression in rat hippocampal neurons and
astrocytes. Neuropharmacology 50: 714–725.
60. Smith-Swintosky VL, Cheo-Isaacs CT, D’Andrea MR, Santulli RJ, Darrow AL,
et al. (1997) Protease-activated receptor-2 (PAR-2) is present in the rat
hippocampus and is associated with neurodegeneration. J Neurochem 69:
1890–1896.
61. Kanke T, Macfarlane SR, Seatter MJ, Davenport E, Paul A, et al. (2001)
Proteinase-activated receptor-2-mediated activation of stress-activated protein
kinases and inhibitory kappa B kinases in NCTC 2544 keratinocytes. J Biol
Chem 276: 31657–31666.
62. Belham CM, Tate RJ, Scott PH, Pemberton AD, Miller HR, et al. (1996)
Trypsin stimulates proteinase-activated receptor-2-dependent and -independent
activation of mitogen-activated protein kinases. Biochem J 320(Pt 3): 939–946.
63. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, et al. (2000) beta-
arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for
intracellular targeting of activated ERK1/2. J Cell Biol 148: 1267–1281.
64. Jin G, Hayashi T, Kawagoe J, Takizawa T, Nagata T, et al. (2005) Deficiency of
PAR-2 gene increases acute focal ischemic brain injury. J Cereb Blood Flow
Metab 25: 302–313.
65. Kennedy PG (2006) Diagnostic and neuropathogenesis issues in human African
trypanosomiasis. Int J Parasitol 36: 505–512.
66. Sternberg JM, Rodgers J, Bradley B, Maclean L, Murray M, et al. (2005)
Meningoencephalitic African trypanosomiasis: Brain IL-10 and IL-6 are
associated with protection from neuro-inflammatory pathology. J Neuroimmunol
167: 81–89.
67. Masocha W, Robertson B, Rottenberg ME, Mhlanga J, Sorokin L, et al. (2004)
Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei
penetration of the blood-brain barrier. J Clin Invest 114: 689–694.
68. Masocha W, Rottenberg ME, Kristensson K (2006) Minocycline impedes
African trypanosome invasion of the brain in a murine model. Antimicrob
Agents Chemother 50: 1798–1804.
69. Cenac N, Chin AC, Garcia-Villar R, Salvador-Cartier C, Ferrier L, et al. (2004)
PAR2 activation alters colonic paracellular permeability in mice via IFN-
gamma-dependent and -independent pathways. J Physiol 558: 913–925.
70. Ishikawa C, Tsuda T, Konishi H, Nakagawa N, Yamanishi K (2009)
Tetracyclines modulate protease-activated receptor 2-mediated proinflamma-
tory reactions in epidermal keratinocytes. Antimicrob Agents Chemother 53:
1760–1765.
71. Lutz S, Freichel-Blomquist A, Yang Y, Rumenapp U, Jakobs KH, et al. (2005)
The guanine nucleotide exchange factor p63RhoGEF, a specific link between
Gq/11-coupled receptor signaling and RhoA. J Biol Chem 280: 11134–11139.
Role of PAR in African Trypanosome BBB Interaction
www.plosntds.org 13 July 2009 | Volume 3 | Issue 7 | e479